StockNews.AI
EXAS
StockNews.AI
4 hrs

Exact Sciences Schedules Third Quarter 2025 Earnings Call

1. EXAS will release Q3 2025 financial results on November 3, 2025. 2. A conference call will follow to discuss business progress and results.

Earnings
+2.19%Current Return
VS
+0.19%S&P 500
$57.7510/08 07:07 AM EDTEvent Start
$59.01310/08 09:59 AM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Neutral?

The scheduled earnings report typically has a neutral impact until results are disclosed. Historical data shows similar pre-announcement periods usually do not lead to significant price movements.

How important is it?

Earnings results are critical indicators for investors; early announcements often set market sentiment.

Why Short Term?

The upcoming earnings report will influence EXAS’s stock in the immediate aftermath of the announcement, similar to past performance.

Related Companies

CMSNTRADGX
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its third quarter 2025 financial results after the close of the U.S. financial markets on November 3, 2025. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress. Third quarter 2025 webcast & conference call details Date: M.

Related News